These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5285372)

  • 21. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of heparin administration on the plasma protein binding and disposition of propranolol.
    Silber B; Lo M; Riegelman S
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):419-29. PubMed ID: 7384636
    [No Abstract]   [Full Text] [Related]  

  • 23. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic clearance of propranolol in dogs.
    Breckenridge A; Buranapong P; Dollery CT; George CF; Macerlean D; Orme ML
    Br J Pharmacol; 1973 Jun; 48(2):336P-337P. PubMed ID: 4733741
    [No Abstract]   [Full Text] [Related]  

  • 25. The fate of isoprenaline administered by pressurized aerosols.
    Blackwell EW; Conolly ME; Davies DS; Dollery
    Br J Pharmacol; 1970 May; 39(1):194P-195P. PubMed ID: 5420096
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoprenaline conjugation--a "true first-pass effect" in the dog intestine.
    Ilett KF; Dollery CT; Davies DS
    J Pharm Pharmacol; 1980 May; 32(5):362. PubMed ID: 6104705
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic studies with inhaled drugs.
    Davies DS
    Eur J Respir Dis Suppl; 1982; 119():67-72. PubMed ID: 6954088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of isoprenaline and other bronchodilator drugs in man and dog.
    Davies DS
    Bull Physiopathol Respir (Nancy); 1972; 8(3):679-83. PubMed ID: 4645577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacodynamic half-life of KO 1366 administered by intravenous and oral route. Comparison with propranolol].
    Hugues FC; Mougeot G; Munera Y; Julien D; Marche J
    Therapie; 1978; 33(3):267-75. PubMed ID: 28580
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
    Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
    Wells PG; Feely J; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time required for complete recovery from chronic propranolol therapy.
    Faulkner SL; Hopkins JT; Boerth RC; Young JL; Jellett LV; Nies AS; Bender HW; Shand DG
    N Engl J Med; 1973 Sep; 289(12):607-9. PubMed ID: 4541874
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoprenaline resistance and the use of pressurised aerosols in asthma.
    Paterson JW; Conolly ME; Davies DS; Dollery CT
    Lancet; 1968 Aug; 2(7565):426-9. PubMed ID: 4174157
    [No Abstract]   [Full Text] [Related]  

  • 38. [Potential and efficacy of the therapeutic use of beta-adrenoblockader electrophoresis (an experimental study)].
    Levchenko NF; Danilova IN; Sharpanova IK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (1):49-52. PubMed ID: 6111862
    [No Abstract]   [Full Text] [Related]  

  • 39. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.
    Castleden CM; George CF; Short MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):121-2. PubMed ID: 619945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of pharmacological half-life of propranolol in man].
    Hugues FC; Mougeot G; Munera Y; Julien D; Marche J
    Therapie; 1977; 32(3):321-8. PubMed ID: 929501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.